Search Results - john+o%27bryan

1 Results Sort By:
Monobody R15 targets the nucleotide free state of RAS to block oncogenic signaling and transformation
Technology: Researchers at MUSC and NYU Langone Medical Center have identified a synthetic protein (R15) that selectively binds to the nucleotide-free state of the RAS proto-oncogene (apoRAS) and is the first experimental tool to selectively inhibit the signaling and oncogenic activity of selected oncogenic RAS mutants (Figure 1). The synthetic protein...
Published: 3/26/2021   |   Inventor(s): John O'Bryan, Shohei Koide, Akiko Koide
Category(s): Therapeutic
© 2021. All Rights Reserved. Powered by Inteum